Skip to main content
LymeCare Alliance Logo
Send Your Case Donate

A Case of Untreated Tick-Borne Infections in the UK: Diagnostic Gaps and Patient Despair

Share on LinkedIn Facebook

Published on:

Introduction

C.E., a male patient from the UK, has been struggling with progressively worsening symptoms over the past five years. His condition initially began with general discomfort but has since escalated into a complex array of debilitating symptoms, including muscle weakness, generalized ligament laxity, derealization, anxiety, dizziness, peripheral neuropathy, pain in his Achilles heel, and blurry vision. Despite his worsening condition, C.E. has not received appropriate medical treatment in the UK due to the limitations of standard diagnostic methods and the refusal of local doctors to acknowledge his positive results from advanced testing abroad.

C.E. underwent a standard ELISA test for Borrelia in the UK, which returned a negative result. However, subsequent ELISpot testing conducted abroad showed weakly positive results for Borrelia, as well as coinfections with Babesia and Bartonella. Despite these findings, his UK-based doctors dismissed the results, claiming that Bartonella is rare in the UK and that the negative ELISA test ruled out any tick-borne infections. As a result, C.E. has been left untreated, and his health continues to decline. The patient has sought alternative treatments, including prolotherapy for ligament instability and herbal remedies, but these interventions have been largely ineffective. In recent weeks, C.E. has expressed suicidal ideation due to the lack of treatment and the severity of his symptoms.

Conclusion

C.E.'s case represents a tragic example of how the limitations of conventional diagnostic methods and lack of awareness around tick-borne infections in the UK can lead to a patient's progressive deterioration. His experience highlights the growing concern around patients suffering from chronic Lyme disease and related infections, who are often left untreated due to negative results from standard tests like ELISA and skepticism regarding the presence of certain pathogens in the UK. C.E.'s declining physical and mental health emphasizes the urgent need for a more comprehensive approach to diagnosing and treating tick-borne infections, as well as providing psychological support for patients who face significant barriers to care.

Medical History

  • Initial Symptoms: Five years ago, C.E. began experiencing general discomfort that was difficult to pinpoint. Over time, his symptoms became more defined, progressing to include muscle weakness and loosening of ligaments throughout his body.
  • Progression of Symptoms: In the years following the onset of his symptoms, C.E. experienced a broad range of additional issues, including severe muscle weakness, derealization (a feeling of being detached from reality), anxiety, and frequent episodes of dizziness. Peripheral neuropathy in his hands and feet became a daily struggle, and he developed pain in his Achilles heel and blurry vision, significantly impacting his quality of life.
  • Diagnostic Journey: C.E. underwent an ELISA test for Borrelia in the UK, which returned a negative result. However, seeking further answers, he performed advanced ELISpot testing abroad, which indicated weak positivity for Borrelia (Lyme disease), as well as the coinfections Babesia and Bartonella. Despite these findings, UK doctors rejected the foreign test results, insisting that Bartonella is extremely rare in the UK and dismissing his symptoms as unrelated to tick-borne infections.

Symptoms

  • Muscle Weakness: C.E. has reported significant loss of muscle strength, which has progressively worsened over the years. The muscle weakness affects his ability to perform daily activities and contributes to overall fatigue.
  • Loose Ligaments: Ligament instability across multiple joints has caused significant pain and dysfunction. This has led C.E. to seek expensive prolotherapy treatments over the past year, but these interventions have not provided lasting relief.
  • Derealization and Anxiety: C.E. experiences frequent episodes of derealization, where he feels disconnected from his surroundings, accompanied by severe anxiety that has affected his mental health.
  • Dizziness: Chronic dizziness has made it difficult for him to maintain balance and has contributed to his overall sense of instability.
  • Peripheral Neuropathy: C.E. suffers from nerve pain, tingling, and numbness in his hands and feet, which complicates his mobility and daily functioning.
  • Achilles Heel Pain: Persistent pain in his Achilles tendons has further limited his physical activity.
  • Blurry Vision: C.E. has noted episodes of blurry vision, which occur intermittently but add to his sense of disorientation and overall discomfort.

Diagnostic Tests

  1. ELISA Test (conducted in the UK): This test for Borrelia returned a negative result. ELISA is a commonly used serological test for Lyme disease, but it is known to have limitations, especially in detecting late-stage or chronic infections, as well as coinfections like Babesia and Bartonella. The negative result led C.E.'s UK doctors to dismiss Lyme disease as a possible diagnosis.
  2. ELISpot Test (conducted abroad): ELISpot testing, which measures cellular immune responses to tick-borne pathogens, indicated weakly positive results for Borrelia (the causative agent of Lyme disease) as well as the coinfections Babesia and Bartonella. These findings suggest that C.E. is dealing with a complex, multisystemic infection involving multiple tick-borne pathogens. Despite this, the results were not recognized by his doctors in the UK.

Outcomes

  • Dismissal by UK Doctors: Despite the positive ELISpot results for multiple infections, C.E.’s UK-based doctors declined to acknowledge the presence of Borrelia, Babesia, or Bartonella. They insisted that Bartonella is not common in the UK, which led to a refusal of treatment and left C.E. without proper medical care.
  • Failed Prolotherapy Treatments: Over the past year, C.E. has spent considerable amounts of money on prolotherapy, a regenerative treatment aimed at addressing his loose ligaments. Unfortunately, this treatment has not provided any significant improvement, leaving him physically weakened and financially burdened.
  • Alternative Herbal Treatments: In the absence of formal medical treatment, C.E. has turned to herbal remedies commonly used for Lyme disease and associated infections. However, the lack of professional medical oversight and the severity of his symptoms mean that these treatments have not been sufficient to halt his condition's progression.
  • Suicidal Ideation: C.E. has shared that he is now experiencing suicidal thoughts due to his ongoing physical decline, the lack of treatment options, and the hopelessness he feels from his doctors’ refusal to acknowledge his illness. This mental health crisis highlights the critical need for psychological support and immediate intervention.

Differential Diagnosis

  • Chronic Lyme Disease and Coinfections (Babesia and Bartonella): The ELISpot test conducted abroad strongly suggests that C.E. is suffering from a complex infection involving Borrelia, Babesia, and Bartonella. Chronic Lyme disease can lead to multisystemic symptoms such as muscle weakness, neurological dysfunction, and joint instability, all of which are present in C.E.’s case. The added complications from Babesia and Bartonella further contribute to his deteriorating health.
  • Ehlers-Danlos Syndrome (EDS): Given the presence of ligament laxity and joint instability, a condition like EDS, which involves defective connective tissue, could be considered in the differential diagnosis. However, the constellation of symptoms and positive test results for tick-borne infections makes chronic Lyme disease and coinfections the more likely diagnosis.
  • Chronic Fatigue Syndrome (CFS) or Fibromyalgia: Conditions such as CFS or fibromyalgia could explain C.E.’s widespread muscle weakness and fatigue, but these diagnoses fail to account for the positive test results for tick-borne infections. These alternative diagnoses are often suggested when patients with Lyme-like symptoms have negative tests from standard Lyme serology, as in C.E.'s case.

Future Recommendations

  • Consultation with an ILADS-Certified Lyme Disease Specialist (LLMD): C.E. is currently planning to consult with an LLMD who specializes in treating chronic Lyme disease and its coinfections. This consultation is critical to developing a comprehensive treatment plan that addresses the underlying infections and his debilitating symptoms. It will likely involve long-term antibiotic therapy and other supportive treatments, given the complexity of his condition.
  • Comprehensive Multisystemic Treatment Approach: C.E.’s condition will likely require a tailored, multisystemic approach that addresses not only the infections but also the damage caused by these pathogens. This could include immune support, therapies to address his ligament instability, and neurological rehabilitation.
  • Psychological Support and Crisis Intervention: Given C.E.’s current mental state and suicidal thoughts, immediate psychological support is crucial. The chronic nature of his illness, compounded by the lack of recognition and support from medical professionals, has contributed to severe emotional distress. Mental health intervention is needed to ensure C.E. has the necessary resources to cope while awaiting treatment.
  • Further Diagnostic Workup for Coinfections: It is essential to confirm the presence of Babesia and Bartonella through additional testing, such as PCR or indirect fluorescent antibody testing. Coinfections often complicate Lyme disease treatment, and their presence will impact the therapeutic strategy moving forward.
  • Long-Term Antibiotic Therapy: Based on the weak positivity for Borrelia, Babesia, and Bartonella, C.E. may require an extended course of antibiotics, possibly including combinations of agents like doxycycline, azithromycin, or antiparasitic medications for Babesia. LLMD guidelines often recommend individualized treatment protocols that can last for months or even years in chronic cases.

Discussion

C.E.'s case highlights the significant challenges faced by patients with suspected chronic Lyme disease and coinfections in the UK, where standard diagnostic tools such as the ELISA test often fail to detect complex infections. The ELISA test is known for its limitations, particularly in late-stage or chronic Lyme disease, where the immune response may be too weak to generate detectable antibody levels. This issue is further compounded by the fact that standard tests often do not screen for European strains (B. Afzelii and B. Garinii) of Borrelia or for coinfections such as Babesia and Bartonella.

The ELISpot test, which detected weak positive results for multiple infections, offers a more sensitive approach by measuring cellular immune responses rather than relying on antibodies alone. However, the failure of UK-based doctors to recognize the validity of these results, particularly for pathogens like Bartonella, which they believe to be rare, has left C.E. without proper treatment. This dismissal of foreign diagnostic methods and the absence of proper follow-up care have contributed to the patient's worsening condition.

The lack of recognition of Bartonella and other tick-borne coinfections in the UK is particularly concerning. Coinfections often exacerbate Lyme disease symptoms and complicate treatment, leading to prolonged and more severe cases of illness. The presence of multiple infections in C.E.'s case likely accounts for the wide range of symptoms he is experiencing, from musculoskeletal issues to neurological impairment.

C.E.’s experience is not unique. Many patients with chronic Lyme disease and coinfections face significant barriers to diagnosis and treatment, particularly in countries where these conditions are not widely recognized. This often forces patients to seek alternative treatments, including costly therapies like prolotherapy or herbal remedies, which may offer little to no relief.

Broader Implications

C.E.’s case underscores the need for updated diagnostic protocols and greater awareness of tick-borne infections in the UK. Patients like C.E., who suffer from chronic symptoms and coinfections, require a more comprehensive approach to diagnosis and treatment, involving sensitive testing methods and long-term care. The absence of recognition for chronic Lyme disease and coinfections like Babesia and Bartonella leaves patients vulnerable to worsening health and, in some cases, psychological despair.

This case also highlights the importance of mental health support for patients dealing with long-term illness. The chronic nature of Lyme disease and the lack of treatment options can take a significant toll on a patient’s mental well-being. Suicidal ideation, as expressed by C.E., must be taken seriously, and immediate intervention is necessary to prevent tragic outcomes.

C.E.’s journey is a stark reminder that medical professionals must remain open to emerging diagnostic techniques and consider the possibility of coinfections in patients presenting with complex, multisystemic symptoms. His planned consultation with an LLMD offers a glimmer of hope, but it also reflects the current reality that patients with chronic Lyme disease and coinfections often must go to extraordinary lengths to find appropriate care.

Analysis of C.E.'s Case: Diagnostic Gaps and Untreated Tick-Borne Infections in the UK

C.E.'s case, a male patient from the UK suffering from a complex array of symptoms over five years, starkly illustrates the significant limitations in diagnosing and managing tick-borne infections, particularly Lyme disease and its coinfections, in the UK healthcare system. This case highlights critical diagnostic and treatment shortcomings that have left C.E. with progressively worsening health and psychological despair, pointing to an urgent need for a more nuanced and comprehensive approach to tick-borne diseases.

Diagnostic Gaps: The Shortcomings of ELISA Testing

One of the most significant failures in C.E.'s case lies in the reliance on the standard ELISA test to rule out Lyme disease, despite its well-documented limitations in detecting chronic or late-stage infections. The ELISA test, which detects antibodies to Borrelia (the causative agent of Lyme disease), has poor sensitivity, particularly in cases where the immune system is unable to mount a sufficient antibody response. This is common in chronic Lyme disease, where the bacterial infection has persisted for years, and the patient's immune response has waned. In C.E.'s case, the negative ELISA result led his UK doctors to dismiss the possibility of Lyme disease entirely, even though the ELISpot test—an advanced diagnostic tool—later detected weakly positive results for Borrelia as well as coinfections with Babesia and Bartonella.

The ELISpot test, which measures cellular immune responses rather than antibody levels, offers a more sensitive alternative to the traditional ELISA test, especially in chronic infections. In C.E.'s case, this test indicated the presence of not only Borrelia but also Babesia (a protozoan parasite) and Bartonella (a bacterial pathogen), both of which are known to complicate Lyme disease and contribute to the multisystemic symptoms he has been experiencing. Despite these findings, C.E.'s UK-based doctors dismissed the foreign test results, asserting that Bartonella is rare in the UK and maintaining that the negative ELISA test was sufficient to rule out Lyme disease.

This rigid adherence to outdated diagnostic protocols exemplifies a broader systemic issue in the UK, where the medical community often overlooks the complexities of tick-borne infections. The failure to recognize the validity of advanced diagnostic techniques, such as ELISpot, leaves patients like C.E. without proper treatment and exacerbates the diagnostic delays that allow chronic infections to progress unchecked.

The Impact of Coinfections: A Complex, Multisystemic Disease

C.E.'s case also highlights the importance of recognizing and addressing coinfections in patients with Lyme disease. The presence of Babesia and Bartonella alongside Borrelia complicates the clinical picture, as each pathogen contributes to a distinct set of symptoms and challenges in treatment. Babesia, for instance, is a protozoan parasite that affects red blood cells, leading to symptoms such as fatigue, dizziness, and anemia, which may overlap with or exacerbate Lyme disease symptoms. Bartonella, on the other hand, is associated with neurological and vascular complications, contributing to C.E.’s peripheral neuropathy, ligament laxity, and psychological symptoms like derealization and anxiety.

Coinfections are a known complicating factor in Lyme disease, often making the disease more severe and harder to treat. Unfortunately, many standard diagnostic protocols do not screen for these additional pathogens, leaving them undetected and untreated. In C.E.'s case, the presence of multiple infections likely accounts for the broad range of debilitating symptoms, from musculoskeletal weakness and ligament instability to neurological dysfunction and severe anxiety.

The failure to address these coinfections further delays effective treatment and worsens patient outcomes. In C.E.'s case, his UK doctors’ refusal to recognize the possibility of Bartonella and Babesia—despite the positive ELISpot results—has left him untreated for years, contributing to his progressive decline and increasing the complexity of his condition.

Psychological Toll: The Consequences of Medical Dismissal

The impact of chronic tick-borne infections is not limited to physical symptoms. C.E.'s case highlights the significant psychological burden that accompanies long-term illness, particularly when patients are dismissed by the medical system. Over the past five years, C.E. has experienced not only debilitating physical symptoms but also severe mental health issues, including derealization, anxiety, and most recently, suicidal ideation. His mental health decline is directly tied to his lack of diagnosis and treatment, compounded by the frustration and hopelessness he feels from being dismissed by his doctors.

The refusal of medical professionals to acknowledge his illness, despite positive diagnostic findings from advanced testing, has left C.E. feeling abandoned by the healthcare system. This emotional distress is a common experience among patients with chronic Lyme disease and coinfections, who are often forced to seek alternative treatments or travel abroad for care when local systems fail them. In C.E.'s case, his attempts at alternative treatments, such as prolotherapy and herbal remedies, have been largely ineffective, adding to his sense of despair and contributing to his current mental health crisis.

It is crucial for healthcare providers to recognize the psychological impact of chronic illness and the emotional toll that comes with being denied appropriate care. C.E.'s suicidal ideation must be taken seriously, and immediate intervention is required to provide him with the mental health support he needs. This case underscores the importance of integrating psychological care into the treatment of chronic Lyme disease and coinfections, especially for patients who have been neglected or misdiagnosed for extended periods.

Future Directions: Comprehensive Treatment and Diagnostic Reform

C.E.’s case demands a comprehensive, multidisciplinary approach to treatment. His planned consultation with an ILADS-certified Lyme disease specialist (LLMD) offers a glimmer of hope, as these specialists are well-versed in the complexities of chronic Lyme disease and coinfections. The treatment plan for C.E. will likely involve long-term antibiotic therapy, possibly in combination with antiparasitic medications for Babesia and targeted therapies for Bartonella. Given the extent of his symptoms and the prolonged duration of his illness, an aggressive, multisystemic approach will be necessary to address not only the infections but also the damage they have caused to his body.

A comprehensive treatment plan for C.E. should also include immune support, rehabilitation for his ligament instability and musculoskeletal weakness, and neurological therapies to address the cognitive and sensory impairments he has experienced. Additionally, psychological support is critical for helping C.E. cope with the emotional toll of his illness and the lack of recognition he has faced from the medical community.

Beyond individual patient care, C.E.'s case highlights the need for broader systemic reforms in the UK. The current reliance on outdated diagnostic methods, such as the ELISA test, is insufficient for detecting chronic or complex tick-borne infections. The UK healthcare system must adopt more sensitive and specific diagnostic tools, like ELISpot and PCR testing, which are better equipped to detect late-stage infections and coinfections. Furthermore, medical professionals need to be educated on the prevalence of tick-borne infections beyond Lyme disease, including pathogens like Babesia and Bartonella, which are often overlooked but can play a significant role in patients’ illness.

Conclusion: Urgent Need for Diagnostic and Therapeutic Reform

C.E.'s case is a powerful example of the consequences of diagnostic gaps and the lack of recognition for chronic tick-borne infections in the UK. His experience highlights the urgent need for healthcare systems to adopt more comprehensive diagnostic tools, recognize the role of coinfections, and provide long-term, multidisciplinary treatment approaches. The refusal to acknowledge advanced test results, coupled with the dismissal of his symptoms, has left C.E. without proper care for years, contributing to his physical and psychological decline.

For patients like C.E., whose lives have been disrupted by untreated infections, a significant shift in medical practice is necessary. This includes not only the integration of advanced diagnostic methods but also the provision of mental health support and a commitment to recognizing and treating the complex, multisystemic nature of chronic Lyme disease and its associated infections. Without these changes, patients like C.E. will continue to suffer needlessly, caught in the gaps of a healthcare system that fails to meet their needs.

Latest Case Studies

Latest publications